Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients
Abstract Many expect genome sequencing (GS) to become routine in patient care and preventive medicine, but uncertainties remain about its ability to motivate participants to improve health behaviors and the psychological impact of disclosing results. In a pilot trial with exploratory analyses, we ra...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b79ae75876f14fea94621325471eb616 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b79ae75876f14fea94621325471eb616 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b79ae75876f14fea94621325471eb6162021-12-02T16:35:01ZBehavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients10.1038/s41525-021-00236-22056-7944https://doaj.org/article/b79ae75876f14fea94621325471eb6162021-08-01T00:00:00Zhttps://doi.org/10.1038/s41525-021-00236-2https://doaj.org/toc/2056-7944Abstract Many expect genome sequencing (GS) to become routine in patient care and preventive medicine, but uncertainties remain about its ability to motivate participants to improve health behaviors and the psychological impact of disclosing results. In a pilot trial with exploratory analyses, we randomized 100 apparently healthy, primary-care participants and 100 cardiology participants to receive a review of their family histories of disease, either alone or in addition to GS analyses. GS results included polygenic risk information for eight cardiometabolic conditions. Overall, no differences were observed between the percentage of participants in the GS and control arms, who reported changes to health behaviors such as diet and exercise at 6 months post disclosure (48% vs. 36%, respectively, p = 0.104). In the GS arm, however, the odds of reporting a behavior change increased by 52% per high-risk polygenic prediction (p = 0.032). Mean anxiety and depression scores for GS and control arms had confidence intervals within equivalence margins of ±1.5. Mediation analyses suggested an indirect impact of GS on health behaviors by causing positive psychological responses (p ≤ 0.001). Findings suggest that GS did not distress participants. Future research on GS in more diverse populations is needed to confirm that it does not raise risks for psychological harms and to confirm the ability of polygenic risk predictions to motivate preventive behaviors.Kurt D. ChristensenErica F. SchonmanJill O. RobinsonJ. Scott RobertsPamela M. DiamondKaitlyn B. LeeRobert C. GreenAmy L. McGuireNature PortfolioarticleMedicineRGeneticsQH426-470ENnpj Genomic Medicine, Vol 6, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Genetics QH426-470 |
spellingShingle |
Medicine R Genetics QH426-470 Kurt D. Christensen Erica F. Schonman Jill O. Robinson J. Scott Roberts Pamela M. Diamond Kaitlyn B. Lee Robert C. Green Amy L. McGuire Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients |
description |
Abstract Many expect genome sequencing (GS) to become routine in patient care and preventive medicine, but uncertainties remain about its ability to motivate participants to improve health behaviors and the psychological impact of disclosing results. In a pilot trial with exploratory analyses, we randomized 100 apparently healthy, primary-care participants and 100 cardiology participants to receive a review of their family histories of disease, either alone or in addition to GS analyses. GS results included polygenic risk information for eight cardiometabolic conditions. Overall, no differences were observed between the percentage of participants in the GS and control arms, who reported changes to health behaviors such as diet and exercise at 6 months post disclosure (48% vs. 36%, respectively, p = 0.104). In the GS arm, however, the odds of reporting a behavior change increased by 52% per high-risk polygenic prediction (p = 0.032). Mean anxiety and depression scores for GS and control arms had confidence intervals within equivalence margins of ±1.5. Mediation analyses suggested an indirect impact of GS on health behaviors by causing positive psychological responses (p ≤ 0.001). Findings suggest that GS did not distress participants. Future research on GS in more diverse populations is needed to confirm that it does not raise risks for psychological harms and to confirm the ability of polygenic risk predictions to motivate preventive behaviors. |
format |
article |
author |
Kurt D. Christensen Erica F. Schonman Jill O. Robinson J. Scott Roberts Pamela M. Diamond Kaitlyn B. Lee Robert C. Green Amy L. McGuire |
author_facet |
Kurt D. Christensen Erica F. Schonman Jill O. Robinson J. Scott Roberts Pamela M. Diamond Kaitlyn B. Lee Robert C. Green Amy L. McGuire |
author_sort |
Kurt D. Christensen |
title |
Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients |
title_short |
Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients |
title_full |
Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients |
title_fullStr |
Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients |
title_full_unstemmed |
Behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients |
title_sort |
behavioral and psychological impact of genome sequencing: a pilot randomized trial of primary care and cardiology patients |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/b79ae75876f14fea94621325471eb616 |
work_keys_str_mv |
AT kurtdchristensen behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients AT ericafschonman behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients AT jillorobinson behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients AT jscottroberts behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients AT pamelamdiamond behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients AT kaitlynblee behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients AT robertcgreen behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients AT amylmcguire behavioralandpsychologicalimpactofgenomesequencingapilotrandomizedtrialofprimarycareandcardiologypatients |
_version_ |
1718383776874102784 |